MIRMHealthcareMid-Cap

Mirum Pharmaceuticals, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Mirum Pharmaceuticals, Inc. (MIRM), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are MIRM insiders buying or selling?

Mirum Pharmaceuticals, Inc. insiders reported 43 open-market buys ($127.3M) and 100 sells ($61.6M) across 143 Form 4 filings — a net buying position of $65.7M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jul 8, 2026)

Total Form 4 filings
143
SEC EDGAR
Insider filers
31
Insider buys (43)
$127.3M
Insider sells (100)
$61.6M

Insider sentiment

Net buying

Net insider flow of $65.7M in net buying.

Recent MIRM insider transactions

DateInsiderRoleTypeSharesPriceValue
Jul 8, 2026Christopher PeetzCHIEF EXECUTIVE OFFICERSale20.0K$122.27$2.4M
Jul 8, 2026Eric BjerkholtCHIEF FINANCIAL OFFICERSale5.0K$122.25$611.3K
Jul 2, 2026Jolanda HoweSVP, GLOBAL CONTROLLERSale2.7K$120.00$326.5K
Jun 18, 2026Jolanda HoweSVP, GLOBAL CONTROLLERSale2.6K$101.95$264.5K
Jun 10, 2026Eric BjerkholtCHIEF FINANCIAL OFFICERSale5.0K$93.82$469.1K
Jun 2, 2026Christopher PeetzCHIEF EXECUTIVE OFFICERSale30.0K$95.84$2.9M
Jun 2, 2026Saira RamasastryDirectorSale4.0K$100.00$397.7K
May 19, 2026Saira RamasastryDirectorSale2.0K$109.47$218.9K
Apr 17, 2026Saira RamasastryDirectorSale2.0K$96.90$193.8K
Mar 17, 2026Eric BjerkholtCHIEF FINANCIAL OFFICERSale7.3K$91.98$670.2K
Mar 17, 2026Joanne QuanCHIEF MEDICAL OFFICERSale7.3K$91.98$670.2K
Mar 17, 2026Saira RamasastryDirectorSale2.0K$90.76$181.5K
Mar 17, 2026Peter RadovichPRESIDENT AND COOSale16.5K$91.98$1.5M
Mar 17, 2026Jolanda HoweSVP, GLOBAL CONTROLLERSale4.7K$91.98$435.2K
Mar 17, 2026Christopher PeetzCHIEF EXECUTIVE OFFICERSale41.0K$91.98$3.8M
Feb 17, 2026Saira RamasastryDirectorSale2.0K$102.09$204.2K
Feb 4, 2026Peter RadovichPRESIDENT AND COOSale2.6K$103.30$271.8K
Feb 4, 2026Christopher PeetzCHIEF EXECUTIVE OFFICERSale9.1K$103.30$940.9K
Feb 4, 2026Jolanda HoweSVP, GLOBAL CONTROLLERSale968$103.30$100.0K
Jan 27, 2026Eric BjerkholtCHIEF FINANCIAL OFFICERSale1.1K$96.19$101.3K
Jan 27, 2026Peter RadovichPRESIDENT AND COOSale3.1K$96.19$302.3K
Jan 27, 2026Jolanda HoweSVP, GLOBAL CONTROLLERSale842$96.19$81.0K
Jan 27, 2026Christopher PeetzCHIEF EXECUTIVE OFFICERSale6.8K$96.19$657.1K
Jan 27, 2026Patrick J HeronDirectorPurchase131.4K$68.48$9.0M
Jan 23, 2026Jolanda HoweSVP, GLOBAL CONTROLLERSale926$93.33$86.4K

Showing the 25 most recent of 143 Form 4 filings for Mirum Pharmaceuticals, Inc..

Most active MIRM insiders

  • Christopher Peetz21 filings
  • Jolanda Howe20 filings
  • Peter Radovich15 filings
  • Patrick J Heron12 filings
  • Saira Ramasastry11 filings

Ask anything about MIRM insider activity

Use Trabud's AI agent to query Mirum Pharmaceuticals, Inc.'s Form 4 history in plain English — "Show me MIRM CEO purchases this year" or compare it against any other ticker.

Open the AI agent

MIRM insider trading FAQ

Are Mirum Pharmaceuticals, Inc. insiders buying or selling?

Across 143 SEC Form 4 filings, Mirum Pharmaceuticals, Inc. (MIRM) insiders reported 43 open-market purchases totaling $127.3M and 100 sales totaling $61.6M. That is a net buying position of $65.7M.

How many insiders trade MIRM stock?

31 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Mirum Pharmaceuticals, Inc.. The most recent filing was accepted on Jul 8, 2026.

Where does Trabud get MIRM insider trading data?

All MIRM insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content